Literature DB >> 2042031

Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis.

E Solcia1, R Fiocca, L Villani, A Gianatti, M Cornaggia, A Chiaravalli, M Curzio, C Capella.   

Abstract

The spectrum of endocrine cell changes occurring in 80 cases of body-fundus chronic atrophic gastritis (CAG), mostly type A or multifocal, including various types of hyperplasia, precarcinoid lesions (20 cases), and neoplasia (carcinoid, 24 cases) have been analyzed histologically, histochemically, and ultrastructurally. Changes associated with gland atrophy, pyloric- or intestinal-type metaplasia, regenerative hyperplasia, and hypergastrinemia have been identified and their neoplastic potential evaluated in the light of their proliferative capacity (bromodeoxyuridine incorporation) and clinicopathologic behavior. A close link between disseminated precarcinoid lesions of non-tumor mucosa and multiple carcinoids (carcinoidosis) arising in hypergastrinemic type-A CAG is suggested. Hyperplastic changes, including endocrine cell clusters, seem to have no or only minimal neoplastic potential.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2042031     DOI: 10.3109/00365529109093193

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  27 in total

Review 1.  Hyperplastic proliferations of enteroendocrine cells.

Authors:  Yogeshwar Dayal
Journal:  Endocr Pathol       Date:  1994-03       Impact factor: 3.943

2.  Lymph node metastasis from gastric carcinoid tumors occurring concomitantly with gastric adenocarcinomas and atrophic gastritis.

Authors:  Rocco Roberto Pidoto; Arnaud Piquard; Fausto Famá; Olivier Saint Marc
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

3.  Observations on relationship between hypergastrinemia, multiple gastric carcinoids, and pancreatic mass.

Authors:  I M Modlin; C J Gilligan; G P Lawton; L H Tang; A B West; R Lindenberg
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

4.  Rapid induction of enterochromaffinlike cell tumors by histamine2-receptor blockade.

Authors:  O Nilsson; B Wängberg; L Johansson; E Theodorsson; A Dahlström; I M Modlin; H Ahlman
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 5.  Acid suppression and gastric mucosal cell biology.

Authors:  G Delle Fave; H Helander; S Holt; I M Modlin; R Powers; E Solcia; A Soll; Y Tielemans; N A Wright
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

6.  Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids.

Authors:  D Granberg; E Wilander; M Stridsberg; G Granerus; B Skogseid; K Oberg
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

Review 7.  Management of gastric polyps: an endoscopy-based approach.

Authors:  Yasser H Shaib; Massimo Rugge; David Y Graham; Robert M Genta
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-10       Impact factor: 11.382

Review 8.  Autoimmune atrophic gastritis--pathogenesis, pathology and management.

Authors:  William L Neumann; Elizabeth Coss; Massimo Rugge; Robert M Genta
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-18       Impact factor: 46.802

Review 9.  Pathophysiological effects of long-term acid suppression in man.

Authors:  R F McCloy; R Arnold; K D Bardhan; D Cattan; E Klinkenberg-Knol; P N Maton; R H Riddell; P Sipponen; A Walan
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

10.  Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia.

Authors:  D B Gough; G B Thompson; T B Crotty; J H Donohue; L K Kvols; J A Carney; C S Grant; D M Nagorney
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.